We have recently reported a role of EOS in AAA and cardiac repair during myocardial infarction and cardiac hypertrophy.[11, 44, 60] ILC2 may use the same mechanisms demonstrated in this study to produce IL5 to control EOS development as an indirect mechanism that protects hearts from infarct injury‐associated cardiac dysfunction. The gene discussed is IL5; the disease is cardiac hypertrophy.